Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1981 Dec 1;154(6):1795–1810. doi: 10.1084/jem.154.6.1795

Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes

PMCID: PMC2186536  PMID: 6172533

Abstract

Comparative quantitative experiments were designed to study the expression of H-2Kd and H-2Dd antigens on three different leukemia cell lines induced by Gross murine leukemia virus (MuLV)in BALB/c (H-2d) mice. The H-2 restriction patterns of syngeneic cytolytic T lymphocytes (CTL) directed against Gross MuLV-induced tumors were correlated with these quantitations of H-2Kd and H-2Dd antigens, Our results obtained by quantitative absorption of monospecific antisera indicated that the three BALB/c tumor cell lines expressed different amounts of H-2Kd and H-2Dd antigens, with H-2Dd antigen showing the greatest variability in expression because it ranged from barely detectable levels to one- eighth the amount of H-2Dd antigen expressed on normal BALB/c spleen cells. The H-2 restriction patterns of Gross MuLV-specific CTL were directly affected by these quantitative modulations in the expression of H-2Kd and H-2Dd antigens, as revealed by three independent approaches: (a) inhibition of CTL activity by monospecific anti-H-2 sera in the absence of complement; (b)competitive inhibition of CTL- mediated cytotoxicity by the addition of excess tumor cells into the reaction mixture; and (c) analysis of CTL specificities using cloned CTL populations. Our results thus indicate that H-2 restriction of tumor-specific CTL activity can be directed at the target cell level by variations in the expression of H-2 antigens.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blank K. J., Lilly F. Evidence for an H-2/viral protein complex on the cell surface as the basis for the H-2 restriction of cytotoxicity. Nature. 1977 Oct 27;269(5631):808–809. doi: 10.1038/269808a0. [DOI] [PubMed] [Google Scholar]
  2. Brunner K. T., Mauel J., Cerottini J. C., Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology. 1968 Feb;14(2):181–196. [PMC free article] [PubMed] [Google Scholar]
  3. Bubbers J. E., Lilly F. Selective incorporation of H-2 antigenic determinants into Friend virus particles. Nature. 1977 Mar 31;266(5601):458–459. doi: 10.1038/266458a0. [DOI] [PubMed] [Google Scholar]
  4. Chesebro B., Wehrly K. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity. J Exp Med. 1976 Jan 1;143(1):85–99. doi: 10.1084/jem.143.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cohen A., Schlesinger M. Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells. Transplantation. 1970 Jul;10(1):130–132. doi: 10.1097/00007890-197007000-00027. [DOI] [PubMed] [Google Scholar]
  6. Doherty P. C., Biddison W. E., Bennink J. R., Knowles B. B. Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. J Exp Med. 1978 Aug 1;148(2):534–543. doi: 10.1084/jem.148.2.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Emerson S. G., Murphy D. B., Cone R. E. Selective turnover and shedding of H-2K and H-2D antigens is controlled by the major histocompatibility complex. Implications for H-2-restricted recognition. J Exp Med. 1980 Oct 1;152(4):783–795. doi: 10.1084/jem.152.4.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Freedman H. A., Lilly F. Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice. J Exp Med. 1975 Jul 1;142(1):212–223. doi: 10.1084/jem.142.1.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GROSS L. Development and serial cellfree passage of a highly potent strain of mouse leukemia virus. Proc Soc Exp Biol Med. 1957 Apr;94(4):767–771. doi: 10.3181/00379727-94-23080. [DOI] [PubMed] [Google Scholar]
  10. Germain R. N., Dorf M. E., Benacerraf B. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor. J Exp Med. 1975 Oct 1;142(4):1023–1028. doi: 10.1084/jem.142.4.1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gomard E., Duprez V., Reme T., Colombani M. J., Levy J. P. Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas. J Exp Med. 1977 Oct 1;146(4):909–922. doi: 10.1084/jem.146.4.909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gomard E., Hénin Y., Colombani M. J., Lévy J. P. Immune response genes control T killer cell response against Moloney tumor antigen cytolysis regulating reactions against the best available H-2 + viral antigen association. J Exp Med. 1980 Jun 1;151(6):1468–1476. doi: 10.1084/jem.151.6.1468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gooding L. R. Anomalous behavior of H-2Kb in immunity to syngeneic SV40 transformed cells: evidence for cytotoxic T cell recognition of H-2/SV40 membrane antigen complexes. J Immunol. 1980 Apr;124(4):1612–1619. [PubMed] [Google Scholar]
  14. Gooding L. R. Antibody blockade of lysis by T lymphocyte effectors generated against syngeneic SV40 transformed cells. J Immunol. 1979 Jun;122(6):2328–2336. [PubMed] [Google Scholar]
  15. Green W. R., Nowinski R. C., Henney C. S. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. J Immunol. 1980 Aug;125(2):647–655. [PubMed] [Google Scholar]
  16. Jones E. A., Bodmer W. F. Lack of expression of HLA antigens on choriocarcinoma cell lines. Tissue Antigens. 1980 Aug;16(2):195–202. doi: 10.1111/j.1399-0039.1980.tb00603.x. [DOI] [PubMed] [Google Scholar]
  17. Meruelo D. A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes. J Exp Med. 1979 Apr 1;149(4):898–909. doi: 10.1084/jem.149.4.898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Old L. J., Boyse E. A., Stockert E. The G (Gross) leukemia antigen. Cancer Res. 1965 Jul;25(6):813–819. [PubMed] [Google Scholar]
  19. Old L. J., Stockert E., Boyse E. A., Kim J. H. Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J Exp Med. 1968 Mar 1;127(3):523–539. doi: 10.1084/jem.127.3.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pfizenmaier K., Jung H., Starzinski-Powitz A., Röllinghoff M., Wagner H. The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes. J Immunol. 1977 Sep;119(3):939–944. [PubMed] [Google Scholar]
  21. Plata F., Goodenow M. M., Lilly F. Studies of cloned Friend erythroleukemia tumor cells. Modulation of the tumor-specific cytologic T lymphocyte response by infectious Friend virus production in vitro. J Exp Med. 1980 Mar 1;151(3):726–742. doi: 10.1084/jem.151.3.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Plata F., Jongeneel V., Cerottini J. C., Brunner K. T. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells. Eur J Immunol. 1976 Nov;6(11):823–829. doi: 10.1002/eji.1830061114. [DOI] [PubMed] [Google Scholar]
  23. Plata F., Lilly F. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus. J Exp Med. 1979 Nov 1;150(5):1174–1186. doi: 10.1084/jem.150.5.1174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sanderson A. R. Quantitative titration, kinetic behaviour, and inhibition of cytotoxic mouse isoantisera. Immunology. 1965 Sep;9(3):287–300. [PMC free article] [PubMed] [Google Scholar]
  25. Scollay R., Jacobs S., Jerabek L., Butcher E., Weissman I. T cell maturation: thymocyte and thymus migrant subpopulations defined with monoclonal antibodies to MHC region antigens. J Immunol. 1980 Jun;124(6):2845–2853. [PubMed] [Google Scholar]
  26. Sommerville J. Serotype transformation in Paramecium aurelia: antigen synthesis after a temperature change. Exp Cell Res. 1969 Oct;57(2):443–446. doi: 10.1016/0014-4827(69)90171-2. [DOI] [PubMed] [Google Scholar]
  27. Taniyama T., Holden H. T. Requirement of histocompatible macrophages for the induction of a secondary cytotoxic response to syngeneic tumor cells in vitro. J Immunol. 1979 Jul;123(1):43–49. [PubMed] [Google Scholar]
  28. Trinchieri G., Aden D. P., Knowles B. B. Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens. Nature. 1976 May 27;261(5558):312–314. doi: 10.1038/261312a0. [DOI] [PubMed] [Google Scholar]
  29. Vickerman K., Luckins A. G. Localization of variable antigens in the surface coat of Trypanosoma brucei using ferritin conjugated antibody. Nature. 1969 Dec 13;224(5224):1125–1126. doi: 10.1038/2241125a0. [DOI] [PubMed] [Google Scholar]
  30. Weiss A., Brunner K. T., MacDonald H. R., Cerottini J. C. Antigenic specificity of the cytolytic T lymphocyte response to murine sarcoma virus-induced tumors. III. Characterization of cytolytic T lymphocyte clones specific for Moloney leukemia virus-associated cell surface antigens. J Exp Med. 1980 Nov 1;152(5):1210–1225. doi: 10.1084/jem.152.5.1210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Zinkernagel R. M., Althage A., Cooper S., Kreeb G., Klein P. A., Sefton B., Flaherty L., Stimpfling J., Shreffler D., Klein J. Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness. J Exp Med. 1978 Aug 1;148(2):592–606. doi: 10.1084/jem.148.2.592. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES